tiprankstipranks
International Stem Cell (ISCO)
OTHER OTC:ISCO
US Market

International Stem Cell (ISCO) Income Statement

Compare
44 Followers

International Stem Cell Income Statement

Last quarter (Q3 2024), International Stem Cell's total revenue was $2.18M, an increase of 10.44% from the same quarter last year. In Q3, International Stem Cell's net income was $-125.00K. See International Stem Cell’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 7.79M$ 8.18M$ 7.18M$ 7.13M$ 9.47M
Gross Profit
$ 4.61M$ 4.91M$ 4.24M$ 4.35M$ 5.54M
Operating Expenses
$ 5.27M$ 5.09M$ 6.16M$ 7.17M$ 11.27M
Depreciation and Amortization
$ 194.00K$ 359.00K$ 551.00K$ 253.00K$ 285.00K
EBITDA
$ 202.00K$ 22.00K$ -220.00K$ -2.36M$ -3.90M
Operating Income
$ -663.00K$ -196.00K$ -1.92M$ -2.82M$ -5.73M
Other Income/Expenses
$ 532.00K$ -148.00K$ 1.02M$ 94.00K$ 1.46M
Pretax Income
$ -131.00K$ -331.00K$ -899.00K$ -2.72M$ -4.26M
Net Income
$ -131.00K$ -466.00K$ -1.04M$ -2.84M$ -4.34M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.02$ -0.06$ -0.13$ -0.38$ -0.58
Diluted EPS
$ -0.02$ -0.06$ -0.13$ -0.38$ -0.58
Weighted Average Shares Outstanding
8.00M 8.00M 7.83M 7.54M 7.51M
Weighted Average Shares Outstanding (Diluted)
8.00M 8.00M 7.83M 7.54M 7.51M
Currency in USD

International Stem Cell Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis